Abstract
Introduction

50
Two cell populations residing within the arcuate nucleus (ARC) of the hypothalamus compose a 51 critical circuit for regulating energy homeostasis: neuropeptide Y (NPY)/agouti-related peptide 52 (AgRP) and proopiomelanocortin (POMC) neurons (12). Selective stimulation of NPY/AgRP 53 neurons via optogenetics evokes intense feeding (3), and ablation of these neurons in adults 54 causes starvation, evidently due to loss of inhibitory signaling to the brain stem (24; 52; 53) . 55
Similar and other approaches have revealed that POMC cells control the exact opposite actions 56 in energy balance (3; 13; 32; 39; 50; 54) . These two populations of neurons are thought to 57 regulate feeding through sensing blood-borne metabolic factors and then synaptically releasing 58 their expressed peptides or derivatives into various brain regions such as the paraventricular 59 nucleus and lateral hypothalamus (12) . 60
Estrogens, such as 17β-estradiol (E2), regulate energy balance in females and exert 61 potent anorectic effects, at least partly through activating POMC neurons (34). E2 increases the 62 expression of POMC and its derived anorectic peptides (30; 44), and deleting the ERα receptor 63 from POMC cells results in hyperphagia and weight gain in females (54). We have shown that 64 E2 rapidly increases the membrane excitability of POMC cells through a novel membrane-65 associated estrogen receptor coupled via Gαq (Gq-mER) to a phospholipase C-protein kinase 66 C-protein kinase A signaling pathway (21; 31; 32) . This mER signaling pathway rapidly 67 attenuates the coupling of GABA B and µ-opioid receptors to G protein-coupled inwardly-68 rectifying K + channels (GIRKs), which upon activation elicit a robust, hyperpolarizing outward 69
current (21; 31). 70
Conversely, E2 attenuates the orexigenic actions of NPY and suppresses its expression 71 (9; 30; 40). In addition, E2 reduces secretion of the peptide from immortalized hypothalamic 72 neurons (11). We have shown that E2 decreases the membrane excitability of NPY/AgRPWe chose to use guinea pigs for the feeding experiments based on our previous publications 122 that the diphenylacrylamide compound STX decreases food intake and weight gain following 123 ovariectomy in females (32; 37; 50) , and the fact that STX is bioavailable (F = 21%) and 124 centrally active in the female guinea pig (35). For the feeding studies, a Comprehensive Lab 125
Animal Monitoring Systems (CLAMS; Columbus Instruments; Columbus, OH) recorded daily 126 food intake in adult, gonadectomized male (n=10) and female guinea pigs (n=12) as previously 127 described (35). Animals received 3 days to acclimate to their CLAMS chambers and daily 128 handling/weighing procedures. After acclimation, analysis of food intake under ad libitum 129 conditions took place for 7 days. Each morning (0800 h), animals were weighed, injected with 130 STX (3 mg, sc) or vehicle (150 µl, sc) and then returned to their CLAMS chambers. 131
Preparation of hypothalamic slices 132
Following rapid decapitation of 2-to 3-month-old mice, brains were extricated and placed in ice-133 
Electrophysiology 141
After at least 1 hour of recovery following collection, the slices were transferred to a recording 142 chamber on an Olympus BX51WI with infrared differential interference contrast imaging and 143 fluorescence. Slices received continuous perfusion of warmed (35°C), carbogenated aCSF at a 144 rate of 2ml/min by peristaltic pump. Drugs were diluted from stock solutions with aCSF in opentop 60ml syringes and perfused throughout the recording chamber by the same pump. All cells 146 were perfused with 0.5 μM TTX 5 min before and then during recording. 147
Whole-cell voltage (-50mV) and current-clamp recording were acquired using 3-4 mΩ 148 borosilicate pipettes (1.5 mm OD; World Precision Instruments, Sarasota, FL) filled with internal 149 solution containing (in mM) 128 potassium gluconate, 10 NaCl, 2 MgCl, 10 HEPES, 11 EGTA, 3 150 ATP and 0.25 GTP (pH 7.26, 296 mOSM). showed a mean RMP of -51.1 ± 0.6 mV (n=113) and average input resistance of 2.3 ± 0.2 GΩ 158
(n=116). 159
The protocol depicted in Figure 1 was used to determine the effect of various 160 pharmacological manipulations on coupling of GABA B receptors to GIRK channels: after 161 obtaining a stable whole-cell configuration, cells were perfused with 0.5 μM TTX for 5 min. 162
Baclofen was then perfused at concentration of 10 μM to reach a steady-state outward current 163 for the first response (R1). After washout of the drug, the current decreased to its resting level. 164
Perfusion of vehicle or the selected treatment took place for 15 min, and then a second 165 response to baclofen (10 μM) was elicited (R2). The magnitude (outward current) of each 166 response was measured, and the effects were expressed as a percentage of R2/R1. 167
NPY/AGRP cell harvesting and reverse transcription
Single-cell harvesting took place as previously described (7; 55). Briefly, following 169 microdissection from the slice, the ARC was incubated in aCSF containing protease (1mg/ml) 170 
Primer design 191
The NPY, GABA B -R1 and GABA B -R2 primer sequences were as previously published (36; 58). 192
Mouse PI3K p110β primers (218 bp product; accession number NM_029094; forward primer, 193 812-833 nt; reverse primer 1010-1029 nt) were designed using the Clone Manager software 194 (Sci Ed Software, Carry, NC). In order to avoid genomic DNA amplification, primer pairs crossed 195 intron-exon boundaries. 196
Single cell PCR 197
Single cell PCR (sc-PCR) required 2-3 µl of cDNA template in a 30 µl PCR mix. Following 198 established protocols (33; 56), forty to fifty cycles of amplification took place with a Bio-Rad 199 C1000 Thermal Cycler (Bio-Rad; Hercules, CA). Ethidium bromide applied to a 2% agarose gel 200 allowed visualization of PCR products, which were confirmed with sequencing. 201
Statistical analysis 202
One-way ANOVA with Newman-Kuels post hoc test was used to compare groups for the 203 electrophysiology experiments. A repeated-measures, multi-factorial ANOVA followed by the 204 Least Significant Difference (LSD) test was used to compare groups for the in vivo feeding 205 experiment. Results were considered significant if the probability of error was < 5%. All data 206 reported as mean ± SEM. 207 NPY/AgRP neurons (n=128) responded to baclofen. A cumulative dose response to the drugapplied at 1, 3, 10 and 30 μM concentrations correspondingly generated a mean steady-state 215 outward current of 4.0 ± 1.1 pA (n=9) , 8.4 ± 1.4 pA (n=23), 14.6 ± 2.1 pA (n=22) and 19.9 ± 3.5 216 pA (n=11) in males and 5.8 ± 2.5 pA (n=2), 7.7 ± 2.2 pA (n=3), 21.6 ± 4.8 pA (n=5) and 28.7 ± 217 5.9 pA (n=7) in ovariectomized females (Figure 2A) . A few cells (n=3) additionally received 65 218 µM baclofen to confirm that 30 µM elicited a maximum response. Normalizing these data to 219 percent maximal outward current revealed that males and females shared a statistically 220 equivalent EC 50 of 4.3 and 4.7 μM, respectively ( Figure 2B ). This is similar to the EC 50 for 221 baclofen-mediated inhibition of POMC neurons (31). In current clamp, 10 µM baclofen 222 hyperpolarized NPY/AgRP cells (n=11) by 16 ± 2 mV and inhibited firing ( Figure 2C ). I-V 223 relationships generated before and after application of the drug showed a reversal potential 224 near E K + (-83 mV), and a 54 ± 0.1% (n=29) increase in slope conductance ( Figure 2D ). BaCl 2 225 (500 µM) abrogated the baclofen response (data not shown), which is consistent with the 226 GABA B receptors activating GIRK channels (20; 28; 41). Single-cell RT-PCR on 40 neurons 227 from 4 animals confirmed that 87.5 ± 4.8 and 72.5 ± 4.8% of NPY/AgRP neurons expressed 228 GABA B -R1 and -R2, respectively ( Figure 3A, B) . 229
Results
208
E2 attenuates but STX enhances GABA B signaling in male NPY/AgRP cells 230
We used the whole-cell voltage-clamp protocol depicted in Figure 1 to measure the rapid effects 231 of E2 on GABA B coupling to GIRK channels in NPY/AgRP neurons, as previously described in 232 POMC cells (31). We used a concentration of 10 μM baclofen to ensure a robust response. 233
Under control conditions (no intervening drug) in intact males, 10 μM baclofen elicited a large 234 response that subsided during a 20-min washout period, and a second, equal-amplitude 235 response thereafter (n=7; Figure 4A , G), suggesting that no rundown or desensitization 236 occurred. Application of E2 (100 nM) during the washout period, which showed no effect on 237 holding current, significantly attenuated the response (outward current) by 42.6 ± 3.5% (n=8; 238 p<0.01; Figure 4B ). E2 did not alter reversal potential (E K + ) for the GABA B mediated effects 239 (data not shown). We have previously shown that the EC 50 for E2 in other ARC neurons is 7.5 240 nM, and the K i for estrogen receptor antagonist ICI 182,780 is 0.3 nM (21). We opted to use a 241 100 nM concentration of E2 to promote more rapid pharmacokinetics in the slice (19; 27; 31) . 242
However, 10 nM E2 similarly attenuated the baclofen response by 52.0 ± 6.5% (n=3). 243
We recently demonstrated that E2 may use a PI3K signaling pathway to attenuate the 244 GABA B response in POMC neurons (26), and hypothesized that E2 may utilize the same 245 pathway in NPY/AgRP neurons. Co-perfusion of the general PI3K blockers wortmannin (100 246 nM; n=5) or LY294002 (10 µM; n=6) with E2 attenuated the suppression of the response (Figure  247 4G). Further, based on the recent work highlighting the specific roles of PI3K isoforms in energy 248 balance (2), we found that TGX-221 (11 nM), a selective inhibitor of PI3K p110β, potently 249 blocked the suppression of the response by E2 (n=4; Figure 4C ). ERα has been shown to 250 complex with PI3K in hypothalamic and cortical neurons (11; 43), so we decided to test 251 specifically if the attenuation of the GABA B response could be mimicked by the ERα-selective 252 agonist PPT (15). Indeed, PPT (100 nM) replicated the effects of E2 to attenuate the GABA B 253 response in NPY/AgRP neurons by 46.7 ± 13.8% (n=4; p<0.001; Figure 4D ). 254
In contrast to the ERα agonist PPT, the Gq-mER ligand STX (100 nM), which shows an 255 ~1 million-fold reduced binding affinity for the nuclear estrogen receptors (α/β) (31; 32), 256 enhanced the GABA B response by 66.7 ± 13.5% (n=5; p<0.001; Figure 4E ). Co-perfusion of the 257 estrogen receptor antagonist ICI 182, 780 (1 µM) abrogated the STX -mediated augmentation of 258 the GABA B response (n=4; Figure 4F ). These data suggest that STX acts specifically on the 259 membrane estrogen receptor (Gq-mER) that we have previously shown modulates POMC 260 neuronal excitability and energy homeostasis (21; 31; 32). 261 E2 and STX enhance GABA B signaling in NPY/AgRP cells from gonadectomized animalsrobust response, which was consistently replicated following washout with vehicle (n=4; Figure  264 5A, G). Application of E2 (100 nM) during the washout period, however, revealed three 265 significantly different sets of responses when compared to the control group. In 29% (7 of 24) of 266 the neurons, E2 significantly reduced the amplitude of the response by 40.4 ± 3.7% (p<0.05; 267
Figure 5B), while in 46% (11 of 24) of the neurons, E2 significantly enhanced the response by 268 53.5 ± 6.6% (p<0.01; Figure 5D ). In the remaining 25% of the neurons (6 of 24), there was no 269 net effect of E2 on the GABA B response ( Figure 5C) ; we believe the apparent lack of an effect in 270 some NPY/AgRP neurons represents an equal balance between the ERα-mediated attenuation 271 and the Gq-mER-mediated enhancement of the GABA B response (see Discussion) . 272
The different responses to E2 (enhancement, attenuation, no effect) showed no 273 apparent anatomical segregation (Figure 6 ), but co-perfusing the PI3K blocker wortmannin (100 274 nM) with E2, which blocked the attenuation of the baclofen response by E2 in the male, isolated 275 the enhancement of the GABA B response in female NPY/AgRP neurons (53.9 ± 18.7% 276 increase; n=4; p<0.05; Figure 5E ). In support of the role of PI3K in mediating the attenuation of 277 the GABA B -GIRK channel coupling, single-cell RT-PCR analysis revealed that 33.3 ± 7.6% of 278 NPY/AgRP neurons (4 mice, 76 cells total) from ovariectomized females expressed PI3K p110β 279 mRNA ( Figure 3A,B) . 280 STX (100nM), which selectively targets the Gq-mER, strictly enhanced the GABA B 281 response in ovariectomized females by 59.7 ± 22.0% (n=4; p<0.05; Figure 5F ), similar to the 282 males. A lower concentration of STX (10 nM) similarly enhanced the GABA B response (50.2 ± 283
4.7%; n=3). 284
Interestingly, NPY/AgRP neurons from orchidectomized males responded to E2 in a 285 similar manner to those from ovariectomized females (p=0.76; Fisher exact probability test): in 286 42% (3 of 7) of the neurons, E2 attenuated the GABA B response by 35.5 ± 9.8%, while itenhanced the response by 84.0 ± 23.0% in 29% (2 of 7) of the neurons (data not shown). E2 288 showed no apparent effect in the remaining 29% (2 of 7) of cells. Co-perfusing wortmannin with 289 E2 isolated the enhancement of the baclofen response (49.7 ± 20.7% increase; n=4; p<0.05; 290 Figure 5G ) in NPY/AgRP cells from orchidectomized males, similar to ovariectomized females. 291
STX application in vivo reduces food consumption 292
We have previously reported that STX reduces food consumption in female guinea pigs (35; 293 50). Here we confirmed these findings and extended them to gonadectomized males. 294
Subcutaneous injections of STX daily (0800 h) for a week significantly reduced daily food 295 consumption by greater than 20% in males and females (n=5-7/group; p<0.0001; F-value=22.6; 296 df=1; Figure 7 ). Although STX did not affect body weight over this short period of administration, 297 our previous work showed that longer-term treatment significantly reduces post-ovariectomy 298 weight gain in females (32; 37). These findings are consistent with the in vitro effects of STX on 299 NPY/AgRP and POMC neurons (21; 31; 32) . 300
Discussion
301
We have shown for the first time that NPY/AgRP cells respond to the GABA B agonist baclofen, 302 and that E2 modulates this robust inhibitory response. Low concentrations of E2 (10 nM) 303 suppressed GABA B signaling in all NPY/AgRP cells from intact male mice, whereas E2 304 suppressed the signaling in only about a third of NPY/AgRP neurons from ovariectomized 305 females and orchidectomized males. In contrast, the Gq-mER selective ligand, STX (10 nM), 306 augmented GABA B signaling in both sexes by greater than 50% and curbed food consumption 307 in guinea pigs. Based on our current findings in NPY/AgRP neurons and previous work in 308 POMC neurons (21; 31; 32; 50), the Gq-mER regulates NPY/AgRP and POMC neurons in a 309 reciprocal manner via enhancing or attenuating GABA B receptor coupling to GIRK channels, 310 respectively. 311 
23; 49; 57). 326
Besides its critical role in reproduction, it has long been recognized that E2 is an 327 anorexigenic hormone, based on the findings that E2 replacement attenuates post-ovariectomy 328 weight gain in rodents through decreasing food intake and increasing energy expenditure (4; 10; 329 12; 29; 35; 54). These actions of E2 are thought to be mediated in a large part by the 330 transcriptional activity of ERα, since a loss of function mutation in the receptor is associated with 331 hyperinsulinemia and obesity in humans (42), and globally deleting it causes obesity in mice 332 (14; 16). Furthermore, conditional deletion of ERα in POMC neurons of female mice results in 333 hyperphagia and weight gain (54), which is not surprising given that E2 regulates the expression 334 of a plethora of genes associated with the control of energy homeostasis (25; 37).
We have identified a novel Gq-mER signaling pathway that is also important for the 336 anorexigenic actions of E2 on POMC neurons (21; 31; 32). We have designed a Gq-mER 337 selective ligand, STX, that potently increases the membrane excitability in POMC cells through 338 attenuating GABA B -GIRK coupling via a PLC-PKC-PKA signaling pathway (31) In addition, STX 339 attenuates the presynaptic, CB1 receptor-mediated decrease in glutamate release, further 340 enhancing the excitability of these neurons (50). STX predictably mimics the anorexigenic 341 effects of E2 to reduce food intake and weight gain following ovariectomy (32; 37). 342
In contrast to its excitatory actions in POMC neurons, the "non-selective" E2 both 343 enhanced and attenuated the GABA B receptor-GIRK channel coupling in NPY/AgRP cells of 344 gonadectomized mice, while the selective Gq-mER ligand STX always enhanced the coupling. 345
Moreover, in intact males, E2 and the selective ERα agonist PPT attenuated GABA B receptor-346 GIRK channel coupling, whereas STX enhanced the coupling in an ICI 182, 780-sensitive 347 manner. These data collectively suggest that E2 suppresses or augments GABA B -mediated 348 currents in these orexigenic neurons through binding ERα or a putative Gq-mER, respectively. Overall, E2 is clearly anorexigenic in females because of its pronounced excitatory effects on 358 POMC neurons (13; 31; 32; 50) . 359
The pathway by which E2-ERα suppresses GABA B signaling in NPY/AgRP neurons 360 appears to require PI3K, specifically the catalytic p110β subunit. We previously reported that E2 361 also suppresses GABA B signaling in POMC neurons, in part via a PI3K signaling pathway (26) . 362 Interestingly, deleting p110β, but not p110α, in POMC cells results in diet-induced obesity, while 363 mice with the same deletion in NPY/AgRP neurons resist obesity (2). These findings would 364 support the argument that the p110β subunit plays a vital role in regulating energy homeostasis. 365
Single-cell PCR verified that NPY/AgRP neurons from ovariectomized females express p110β 366 mRNA (Figure 3) , and blockade of PI3K or selective blockade of the p110β catalytic subunit 367 abrogated the inhibitory effects of E2 on GABA B receptor-GIRK channel coupling. Since the 368 selective ERα agonist PPT mimicked the inhibitory effects of E2 on the coupling, presumably 369 increasing membrane excitability, the PI3K signaling pathway may underlie the stimulatory 370 effects of NPY on GnRH and LH secretion in females (1; 5). Indeed, NPY mRNA expression 371 increases in the ARC at the time of the preovulatory LH surge in female rats (6). The Gq-mER 372 signaling pathway in NPY/AgRP and POMC neurons may, therefore, be specific for the control 373 of energy homeostasis, whereas the ERα-PI3K pathway in NPY/AgRP neurons may be 374 exclusive for the reproductive pathway. 375
The anorexigenic actions of E2 are critical throughout the lifespan of women, who show 376 increased risk for insulin resistance, central adiposity and cardiovascular disease during 377 menopause (8). Although E2 replacement (i.e., hormone replacement therapy, HRT) can help 378 reverse these effects, HRT also increases the risk for cancer and stroke (38; 51). Selective 379 activation of Gq-mER, on the other hand, elicits robust anorexigenic effects without the systemic 380 risks associated with activating transcription factors ERα and ERβ (35) . 381
Here we have shown that E2 via a putative Gq-mER rapidly enhances the coupling of 382 GABA B receptors to GIRK channels in NPY/AgRP neurons, thereby increasing the inhibitory 383 tone in these orexigenic cells. Our previous work has shown that STX exerts the exact opposite elicited two equal-amplitude responses during perfusion of vehicle (n=7), but E2 suppressed the 623 response (n=8). Coperfusing general PI3K inhibitors (WRT =wortmannin, 100 nM, n=5; 624 LY=LY294002, 10 µM, n=4) or the p110β inhibitor TGX-221 (TGX, 11 nM, n=6) with E2 625 reversed this effect. PPT mimicked the effects of E2 (n=4). STX augmented the response (n=5), 626 but was rendered ineffective by co-perfusing an estrogen receptor antagonist (ICI=ICI 182, 780, 627 1µM, n=4). **p<0.01; ***p<0.001, versus vehicle control group. shows the average change in food consumption per day in male and female guinea pigs 653 following daily injections with vehicle (n=5 males, 5 females) or STX (n=5 males, 7 females) for 654 one week. ***p<0.0001 versus vehicle control group. Partitioning these data into light and dark 655 periods shows that STX-treated males consumed significantly less during the light period
